MOS
BLUE

MGO One Seven’s bluebird bio BLUE Stock Holding History

MGO One Seven’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$47K Buy
21
+20
+2,000% +$50.9K 0.02% 620
2017
Q4 		$3K Buy
+1
New +$2.03K ﹤0.01% 1419

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MGO One Seven's BLUE Position: Q1 2018 in Review

MGO One Seven increased its bluebird bio (BLUE) stake by 2,000% in Q1 2018, buying an estimated $50.9K and bringing the position to 21 shares worth $47K. The position accounts for 0.02% of the portfolio, ranked #620.

MGO One Seven first reported a position in BLUE in Q4 2017 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • MGO One Seven held 21 shares of bluebird bio worth $47K as of Q1 2018.
  • MGO One Seven bought 20 bluebird bio shares in Q1 2018, an estimated $50.9K.
  • bluebird bio made up 0.02% of MGO One Seven's portfolio in Q1 2018, its #620 holding.
  • MGO One Seven first reported a position in bluebird bio in Q4 2017 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.